NCT06808061

Brief Summary

The objective of this study is to recruit 60 healthy moderately overweight subjects to participate in a research study investigating the effects of a specific probiotic strain (Lactobacillus plantarum KABP-51) on measures of psychological mood state, gut microbiome status, stress hormones, and body composition (body fat and muscle mass). Our subjects will be measured 4 times over the course of a 12-week supplementation period - at Baseline, Week 4, Week 8, and Week 12. We will have 2 groups (N=30 per group):

  • Probiotic Lactobacillus plantarum KABP-51
  • Placebo (maltodextrin/corn starch) Subjects will be recruited from local fitness/wellness centers and businesses (e.g. Plymouth Fitness; Planet Fitness; Marathon Sports, etc) using a simple flyer. If volunteers meet the inclusion/exclusion criteria, they will review/sign the Informed Consent Form (ICF) before any Baseline measurements are collected. Participants will meet weekly (via online webinar) for educational sessions on nutrition, exercise, sleep, stress, and related healthy lifestyle topics. This periodic contact is extremely effective for maintaining compliance with the supplementation regimen and reducing dropouts. Our expectation is that this fairly simple 12-week design will show that the KABP-51 probiotic strain can support a variety of psychological benefits such as reduced stress and improved mood; as well as physical benefits such as improved stress hormone exposure and microbiome balance - all of which may lead to improved body composition (lower body fat and improved muscle mass).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 14, 2023

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 15, 2023

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 15, 2023

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

January 29, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 5, 2025

Completed
Last Updated

February 5, 2025

Status Verified

January 1, 2025

Enrollment Period

5 months

First QC Date

January 29, 2025

Last Update Submit

January 29, 2025

Conditions

Keywords

microbiomeprobioticpsychobioticweight lossbody compositionobesitydepressiondysbiosis

Outcome Measures

Primary Outcomes (1)

  • Body Weight

    12 weeks

Secondary Outcomes (2)

  • Microbiome Balance

    12 weeks

  • Mood State

    12 weeks

Study Arms (2)

Probiotic

EXPERIMENTAL

Lactobacillus plantarum KABP-51; 1-billion CFU

Dietary Supplement: Lactobacillus plantarum

Placebo

PLACEBO COMPARATOR

Maltodextrin

Dietary Supplement: Placebo

Interventions

Lactobacillus plantarumDIETARY_SUPPLEMENT

Lactobacillus plantarum KABP-51

Probiotic
PlaceboDIETARY_SUPPLEMENT

maltodextrin

Placebo

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • healthy moderately overweight

You may not qualify if:

  • Pregnant women
  • Inability to complete prescribed supplement regimen
  • Current use of incompatible medications or supplements (weight loss, mood support, or blood sugar balance)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

3Waves Wellness

Plymouth, Massachusetts, 02360, United States

Location

MeSH Terms

Conditions

Weight LossObesityDepressionDysbiosis

Condition Hierarchy (Ancestors)

Body Weight ChangesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBehavioral SymptomsBehaviorPathologic Processes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Scientist

Study Record Dates

First Submitted

January 29, 2025

First Posted

February 5, 2025

Study Start

February 14, 2023

Primary Completion

July 15, 2023

Study Completion

October 15, 2023

Last Updated

February 5, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations